MANHATTAN SCIENTIFICS, INC. (OTCMKTS:MHTX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On November 22, 2016, Larry H. Schatz, a member of the board of
directors of Manhattan Scientifics, Inc., resigned from the board
of directors.
About MANHATTAN SCIENTIFICS, INC. (OTCMKTS:MHTX)
Manhattan Scientifics, Inc. operates as a technology incubator that seeks to acquire, develop and commercialize technologies in various fields, with emphasis in the areas of nanotechnology. The Company is focused on technology transfer and commercialization of transformative technologies in the nano medicine space. The Company has two subsidiaries, both focused on nanotechnology applications in medicine: Metallicum, Inc. and Senior Scientific LLC. The Company’s bioimaging and nanomagnetic detection systems have been developed to detect cancer and other diseases earlier and with specificity. It has developed hardware and software for the sensitive detection of nanomagnetic particles that can be linked to antibodies for the detection and treatment of cancer and other human diseases, all without the use of ionizing radiation or large magnetic fields. Its technologies make possible the earlier detection of cancer in vivo, and the ability to analyze biopsies with sensitivity. MANHATTAN SCIENTIFICS, INC. (OTCMKTS:MHTX) Recent Trading Information
MANHATTAN SCIENTIFICS, INC. (OTCMKTS:MHTX) closed its last trading session up +0.0014 at 0.0340 with 26,687 shares trading hands.
